 |
Methyl 3-((2R)-2-hydroxy-4-(((((S)-1-methoxy-1-oxopropan-2-yl) amino)(phenoxy)phosphoryl)oxy)-3,3-dimethylbutanamido)propanoate |
|---|---|
| Trade Name | |
| Orphan Indication | Pantothenate-kinase-associated neurodegeneration |
| EU Market Approval | EU |
| EU Designation Date | 2016-02-17 00:00:00 |
| Sponsor | Retrophin Europe Limited |
